B
Boundless Bio, Inc. (BOLD)
NMS – Real Time Price. Currency in USD
1.11
0.00 (0.00%)
At close: Mar 27, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
NMS – Real Time Price. Currency in USD
1.11
0.00 (0.00%)
At close: Mar 27, 2026, 4:00 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 8.74 | 6.05 | 10 | |
| Quick ratio | 8.74 | 5.63 | 10 | |
| Debt to Equity | 0.50 | 0.30 | 7.0 | |
| Debt to Assets | 0.31 | 1.04 | 6.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 6.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -942K | -957K | -1M | -1M | -1M |
| Operating Income | -46M | -55M | -73M | -64M | -64M |
| Net Income | -46M | -49M | -65M | -58M | -58M |
| EBITDA | -46M | -54M | -72M | -62M | -62M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 18.78 | 5.0 |
| Next quarter | N/A | 13.81 | 4.5 |
| Current year | N/A | 8.33 | 3.5 |
| Next year | N/A | 46.15 | 5.5 |
| Weighted average score | 4.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 7.16 | 6.45 | -3.13 | 5.3 |
| Y/Y | 999 | 21.66 | 21.62 | 34.3 | 10 |
| 3y average | 999 | -9.64 | 61.5 | -8.23 | 5.5 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 5.5 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $49.0M significantly exceeds cash reserves ($17.9M), raising financial stability concerns
Total current assets $109.6M exceed Total current liabilities $12.5M, highlighting excellent liquidity
Debt-to-equity ratio (0.5) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$10.5M limits the company's ability to reinvest or pay down debt